I think it’s fair to say then that as long as the science works, then we are well positioned to capitalise on the opportunity!!
OVF, completely speculative, but do you see Dimerix making a partnership agreement with a Big Pharma for the US region if the March interim readout is positive? Or would it be a smaller company like Advanz?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.015(2.75%) |
Mkt cap ! $332.0M | |||
| Open | High | Low | Value | Volume |
| 54.5¢ | 58.5¢ | 54.5¢ | $1.172M | 2.059M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35713 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |